Literature DB >> 26069168

Propensity score-based survival benefit of simultaneous liver-kidney transplant over liver transplant alone for recipients with pretransplant renal dysfunction.

Pratima Sharma1, Xu Shu2, Douglas E Schaubel2, Randall S Sung3, John C Magee3.   

Abstract

The survival benefit of simultaneous liver-kidney transplantation (SLKT) over liver transplantation alone (LTA) is unclear from the current literature. Additionally, the role of donor kidney quality, measured by the kidney donor risk index (KDRI), in survival benefit of SLKT is not studied. We compared survival benefit after SLKT and LTA among recipients with similar pretransplant renal dysfunction using novel methodology, specifically with respect to survival probability and area under the survival curve by dialysis status and KDRI. Data were obtained from the Scientific Registry of Transplant Recipients. The study cohort included patients with pre-liver transplantation (LT) renal dysfunction who were wait-listed and received either a SLKT (n = 1326) or a LTA (n = 4283) between March 1, 2002 and December 31, 2009. Inverse Probability of Treatment Weighting-SLKT and LTA survival curves, along with the 5-year area under the survival curve, were computed by dialysis status at transplant. The difference in the area under the curve represents the average additional survival time gained via SLKT over LTA. For patients not on dialysis, SLKT resulted in a significant 3.7-month gain in 5-year mean posttransplant survival time. The decrease in mortality rate differs significantly by KDRI, and an estimated 76% of SLKT recipients received a kidney with KDRI sufficiently low for mortality. The mortality decrease for SLKT was concentrated in the first year after transplant. The difference between SLKT and LTA 5-year mean posttransplant survival time was 1.4 months and was nonsignificant for patients on dialysis. In conclusion, the propensity score-adjusted survival among SLKT and LTA recipients was similar for those who were on dialysis at LT. Although statistically significant, the survival advantage of SLKT over LTA was of marginal clinical significance among patients not on dialysis and occurred only if the donor kidney was of sufficient quality. These results should be considered in the ongoing debate regarding the allocation of kidneys to extra-renal transplant candidates.
© 2015 American Association for the Study of Liver Diseases.

Entities:  

Mesh:

Year:  2016        PMID: 26069168      PMCID: PMC4674390          DOI: 10.1002/lt.24189

Source DB:  PubMed          Journal:  Liver Transpl        ISSN: 1527-6465            Impact factor:   5.799


  23 in total

1.  Marginal structural models and causal inference in epidemiology.

Authors:  J M Robins; M A Hernán; B Brumback
Journal:  Epidemiology       Date:  2000-09       Impact factor: 4.822

2.  Combined liver-kidney and liver transplantation in patients with renal failure outcomes in the MELD era.

Authors:  Timothy M Schmitt; Sean C Kumer; Abdullah Al-Osaimi; Neeral Shah; Curtis K Argo; Carl Berg; Timothy L Pruett; Patrick G Northup
Journal:  Transpl Int       Date:  2009-04-27       Impact factor: 3.782

Review 3.  Scientific Registry of Transplant Recipients: collecting, analyzing, and reporting data on transplantation in the United States.

Authors:  Susan Leppke; Tabitha Leighton; David Zaun; Shu-Cheng Chen; Melissa Skeans; Ajay K Israni; Jon J Snyder; Bertram L Kasiske
Journal:  Transplant Rev (Orlando)       Date:  2013-03-06       Impact factor: 3.943

4.  Combined liver-kidney transplantation is preferable to liver transplant alone for cirrhotic patients with renal failure.

Authors:  Tse-Ling Fong; Saro Khemichian; Tariq Shah; Ian V Hutchinson; Yong W Cho
Journal:  Transplantation       Date:  2012-08-27       Impact factor: 4.939

5.  Revisiting multi-organ transplantation in the setting of scarcity.

Authors:  P P Reese; R M Veatch; P L Abt; S Amaral
Journal:  Am J Transplant       Date:  2014-01       Impact factor: 8.086

Review 6.  Simultaneous liver-kidney transplantation summit: current state and future directions.

Authors:  M K Nadim; R S Sung; C L Davis; K A Andreoni; S W Biggins; G M Danovitch; S Feng; J J Friedewald; J C Hong; J A Kellum; W R Kim; J R Lake; L B Melton; E A Pomfret; S Saab; Y S Genyk
Journal:  Am J Transplant       Date:  2012-07-23       Impact factor: 8.086

7.  Simultaneous liver-kidney versus liver transplantation alone in patients with end-stage liver disease and kidney dysfunction not on dialysis.

Authors:  A L Mindikoglu; J P Raufman; S L Seliger; C D Howell; L S Magder
Journal:  Transplant Proc       Date:  2011-09       Impact factor: 1.066

8.  Double inverse-weighted estimation of cumulative treatment effects under nonproportional hazards and dependent censoring.

Authors:  Douglas E Schaubel; Guanghui Wei
Journal:  Biometrics       Date:  2011-03       Impact factor: 2.571

9.  Simultaneous liver-kidney transplantation: a survey of US transplant centers.

Authors:  M K Nadim; C L Davis; R Sung; J A Kellum; Y S Genyk
Journal:  Am J Transplant       Date:  2012-07-03       Impact factor: 8.086

10.  A comprehensive risk quantification score for deceased donor kidneys: the kidney donor risk index.

Authors:  Panduranga S Rao; Douglas E Schaubel; Mary K Guidinger; Kenneth A Andreoni; Robert A Wolfe; Robert M Merion; Friedrich K Port; Randall S Sung
Journal:  Transplantation       Date:  2009-07-27       Impact factor: 4.939

View more
  24 in total

1.  A C-index for recurrent event data: Application to hospitalizations among dialysis patients.

Authors:  Sehee Kim; Douglas E Schaubel; Keith P McCullough
Journal:  Biometrics       Date:  2017-08-03       Impact factor: 2.571

Review 2.  Chronic Kidney Disease and Related Long-Term Complications After Liver Transplantation.

Authors:  Pratima Sharma; Khurram Bari
Journal:  Adv Chronic Kidney Dis       Date:  2015-09       Impact factor: 3.620

Review 3.  CON: Liver Transplant Alone.

Authors:  Gina Choi
Journal:  Clin Liver Dis (Hoboken)       Date:  2021-01-13

4.  The proportion of Model for End-stage Liver Disease Sodium score attributable to creatinine independently predicts post-transplant survival and renal complications.

Authors:  Therese Bittermann; Rebecca A Hubbard; James D Lewis; David S Goldberg
Journal:  Clin Transplant       Date:  2020-02-20       Impact factor: 2.863

5.  Racial/Ethnic Disparities in Access and Outcomes of Simultaneous Liver-Kidney Transplant Among Liver Transplant Candidates With Renal Dysfunction in the United States.

Authors:  Su-Hsin Chang; Mei Wang; Xiaoyan Liu; Tarek Alhamad; Krista L Lentine; Mark A Schnitzler; Graham A Colditz; Yikyung Park; William C Chapman
Journal:  Transplantation       Date:  2019-08       Impact factor: 4.939

6.  Is Prioritization of Kidney Allografts to Combined Liver-Kidney Recipients Appropriate? CON.

Authors:  Xingxing S Cheng
Journal:  Kidney360       Date:  2021-10-15

7.  Baseline and Center-Level Variation in Simultaneous Liver-Kidney Listing in the United States.

Authors:  Xun Luo; Allan B Massie; Christine E Haugen; Rashikh Choudhury; Jessica M Ruck; Ashton A Shaffer; Sheng Zhou; Dorry L Segev; Jacqueline M Garonzik-Wang
Journal:  Transplantation       Date:  2018-04       Impact factor: 4.939

Review 8.  Simultaneous liver-kidney transplantation or liver transplantation alone for patients in need of liver transplantation with renal dysfunction.

Authors:  Phuong-Thu T Pham; Keri E Lunsford; Suphamai Bunnapradist; Gabriel M Danovitch
Journal:  Curr Opin Organ Transplant       Date:  2016-04       Impact factor: 2.640

9.  Temporal Trends and Evolving Outcomes After Simultaneous Liver-Kidney Transplantation: Results from the US SLKT Consortium.

Authors:  Giuseppe Cullaro; Pratima Sharma; Jennifer Jo; Jasmine Rassiwala; Lisa B VanWagner; Randi Wong; Jennifer C Lai; John Magee; Aaron Schluger; Pranab Barman; Yuval A Patel; Kara Walter; Scott W Biggins; Elizabeth C Verna
Journal:  Liver Transpl       Date:  2021-08-20       Impact factor: 5.799

10.  Development and Validation of a Model to Predict Long-Term Survival After Liver Transplantation.

Authors:  David Goldberg; Alejandro Mantero; Craig Newcomb; Cindy Delgado; Kimberly Forde; David Kaplan; Binu John; Nadine Nuchovich; Barbara Dominguez; Ezekiel Emanuel; Peter P Reese
Journal:  Liver Transpl       Date:  2021-06       Impact factor: 5.799

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.